Banner - Collaborative Care Symposium

Michael W. Belin, MD

Articles by Michael W. Belin, MD

Keratoconus progression: Looking beyond Kmax

ByMichael W. Belin, MD

January 16th 2019

CXL has potential to alter disease course; progression display plays role in when to intervene

Latest Updated Articles

Keratoconus progression: Looking beyond Kmax
Published: January 16th 2019 | Updated:

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

US FDA awards Epion Therapeutics EpiSmart cross-linking system Fast Track designation

Abeona Therapeutics’ ABO-503 chosen for FDA's Rare Disease Endpoint Advancement Pilot Program

Treating myopia today: US-focused treatments, challenges, and global insights

© 2025 MJH Life Sciences^®

All rights reserved.